94 results
8-K
COCP
Cocrystal Pharma Inc
19 May 11
Completion of Acquisition or Disposition of Assets
12:00am
-greasy concentrated facial formula that provides maximum moisturization of the skin.
Growth Strategy
Our growth strategy is based on the following … and/or in-license new branded dermatological products for sale to our customers
Acquire businesses that can contribute to our growth strategy
Establish co
8-K
COCP
Cocrystal Pharma Inc
7 Jul 11
Acquires Biozone Laboratories, Inc. and Related Companies
12:00am
or current facts. These statements are likely to address our growth strategy, financial results and our ability to develop or acquire new products … business strategy for our health care product business is to grow the portfolio of our proprietary OTC, cosmetic and beauty and physician use brands
8-K
EX-10.11
COCP
Cocrystal Pharma Inc
7 Jul 11
Acquires Biozone Laboratories, Inc. and Related Companies
12:00am
the right to approve and comment on the strategy and prosecution of any such suit. In any of the foregoing suits, Licensee may, at Licensee's expense … on the strategy and prosecution of any such suit. and Licensor may, in Licensor's discretion and at Licensor';, sole expense, retain counsel of its own
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
11 Mar 19
Cocrystal Pharma Announces Closing of Private Placement
8:35am
. This common stock only financing represents an important step in our overall strategy of growing our business in a manner that respects shareholder
8-K
EX-99.1
lgjb zoii
7 Jan 19
Cocrystal Pharma Announces Exclusive Worldwide License and Collaboration Agreement with Merck
9:03am
8-K
68p08td3mm29p2qgnf4
9 Sep 13
Completion of Acquisition or Disposition of Assets
12:00am
S-1
d6c8 t6hy6lrvq0y
21 Sep 11
IPO registration
12:00am
D
l81r9
5 Sep 13
$2M in options, sold $2M, 1 investor
12:00am
D
dzsoopp3z5nol
22 Apr 13
Indefinite amount in equity / options, sold $800K, 5 investors
12:00am
8-K
EX-99.1
6bn 3ea4h
30 Mar 20
Cocrystal Pharma Reports 2019 Financial Results and Outlines Expected Value-Driving Milestones for 2020
6:10am
424B3
8azse
9 Oct 07
Prospectus supplement
12:00am
424B7
2hw4m4bt d90t1rolg2c
26 Feb 13
Prospectus with selling stockholder info
12:00am
8-K
EX-99.1
3b2 fvknmbgk
23 Mar 22
Cocrystal Pharma Reports 2021 Financial Results and Provides Updates on Development Programs and Milestones
4:05pm
10-K
6x5uvw tva
31 Mar 09
Annual report
12:00am